Molitch, Mark E <br/><br/>
Pituitary tumors: cabergoline versus bromocriptine: a meta-analysis?  [electronic resource] 

 -  Nature reviews. Endocrinology  May 2011 
 - 254-5 p.  digital 
<br/><br/> Publication Type: News 
<br/><br/><label>ISSN: </label>1759-5037 
<br/><br/><label>Standard No.: </label>10.1038/nrendo.2011.33  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Bromocriptine--therapeutic use<br/>Cabergoline<br/>Ergolines--therapeutic use<br/>Humans<br/>Meta-Analysis as Topic<br/>Pituitary Neoplasms--drug therapy<br/>Treatment Outcome